Kronos Bio Inc (KRON)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2000 | 09-1999 | |
| Cash Flows From Operating Activities | ||
| Net Income | 15,701 | 22,378 |
| Depreciation Amortization | 22,438 | 18,399 |
| Income taxes - deferred | -3,860 | -3,031 |
| Accounts receivable | -3,620 | -15,765 |
| Other Working Capital | 4,873 | 14,201 |
| Other Operating Activity | 8,419 | 19,227 |
| Operating Cash Flow | $43,951 | $55,409 |
| Cash Flows From Investing Activities | ||
| Change In Deposits | 14,055 | -20,253 |
| PPE Investments | -29,479 | -25,058 |
| Net Acquisitions | -9,009 | -10,260 |
| Investing Cash Flow | $-24,433 | $-55,571 |
| Cash Flows From Financing Activities | ||
| Common Stock Issued | 7,566 | 6,100 |
| Common Stock Repurchased | -23,505 | -15,710 |
| Financing Cash Flow | $-15,939 | $-9,610 |
| Exchange Rate Effect | -526 | 32 |
| Beginning Cash Position | 20,148 | 29,888 |
| End Cash Position | 23,201 | 20,148 |
| Net Cash Flow | $3,053 | $-9,740 |
| Free Cash Flow | ||
| Operating Cash Flow | 43,951 | 55,409 |
| Capital Expenditure | -29,479 | -25,058 |
| Free Cash Flow | 14,472 | 30,351 |